Simplex Trading, LLC Biocryst Pharmaceuticals Inc Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 26,565 shares of BCRX stock, worth $211,988. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,565

Previous 17,095 55.4%

Holding current value

$211,988

Previous $86,000 90.7%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$4.13 - $6.79 $39,111 - $64,301	9,470 Added 55.4%	26,565 $164,000
Q1 2024 Apr 25, 2024	BUY	$4.89 - $7.65 $83,594 - $130,776	17,095 New	17,095 $86,000
Q3 2023 Nov 01, 2023	BUY	$6.71 - $7.92 $54,109 - $63,866	8,064 New	8,064 $57,000
Q1 2023 Apr 27, 2023	BUY	$7.94 - $11.84 $184,454 - $275,055	23,231 Added 57.96%	63,313 $528,000
Q4 2022 Feb 02, 2023	BUY	$10.5 - $14.2 $420,861 - $569,164	40,082 New	40,082 $460,000
Q2 2022 Aug 03, 2022	BUY	$7.89 - $17.88 $166,281 - $376,821	21,075 Added 31.84%	87,260 $923,000
Q1 2022 May 02, 2022	BUY	$11.56 - $19.76 $714,003 - $1.22 Million	61,765 Added 1397.4%	66,185 $1.08 Million
Q4 2021 Feb 23, 2022	SELL	$11.18 - $15.46 $528,981 - $731,489	-47,315 Reduced 91.46%	4,420 $61,000
Q3 2021 Oct 28, 2021	SELL	$14.21 - $17.65 $18,103 - $22,486	-1,274 Reduced 2.4%	51,735 $841,000
Q2 2021 Aug 12, 2021	BUY	$9.5 - $17.24 $124,811 - $226,499	13,138 Added 32.95%	53,009 $838,000
Q1 2021 Apr 26, 2021	SELL	$7.37 - $13.61 $1.55 Million - $2.87 Million	-210,641 Reduced 84.08%	39,871 $0
Q4 2020 Feb 02, 2021	BUY	$3.37 - $8.61 $756,207 - $1.93 Million	224,394 Added 859.15%	250,512 $1.87 Million
Q3 2020 Oct 14, 2020	BUY	$3.43 - $5.53 $53,778 - $86,704	15,679 Added 150.2%	26,118 $89,000
Q2 2020 Jul 13, 2020	BUY	$1.9 - $5.61 $19,834 - $58,562	10,439 New	10,439 $49,000
Q1 2020 Apr 29, 2020	SELL	$1.6 - $4.11 $4,644 - $11,931	-2,903 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$1.59 - $3.45 $4,615 - $10,015	2,903 New	2,903 $10,000
Q1 2019 Apr 18, 2019	SELL	$7.38 - $9.72 $27,173 - $35,789	-3,682 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$6.51 - $9.6 $23,540 - $34,713	-3,616 Reduced 49.55%	3,682 $29,000
Q3 2018 Oct 23, 2018	BUY	$5.52 - $7.99 $40,284 - $58,311	7,298 New	7,298 $55,000

Others Institutions Holding BCRX

# of Institutions

258

Shares Held

173M

Call Options Held

397K

Put Options Held

444K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.48B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Biocryst Pharmaceuticals Inc Transaction History